The effect of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices in rats with polycystic ovary syndrome

다국어 초록 (Multilingual Abstract)

Objective: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, irregular menstruation, ovulatory dysfunction, and insulin resistance. Recent studies have reported the possible role of phytoestrogens in PCOS. This animal study aimed to evaluate the effects of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices on PCOS. Methods: PCOS was induced by 1 mg/kg of letrozole in adult Sprague-Dawley rats. The rats then received normal saline (PCOS group), 150 mg/kg of metformin, or 20 mg/kg of genistein dissolved in 1% methylcellulose solution for 42 days. Body weight, the glycemic and lipid profile, and inflammatory, antioxidative, and histopathological parameters were assessed at the end of the intervention. Results: Treatment with genistein significantly alleviated the increased level of fasting blood insulin (p=0.16) and the homeostatic model assessment of insulin resistance (p=0.012). In addition, the genistein group had significantly lower levels of serum malondialdehyde (p=0.039) and tumor necrosis factor-alpha (p=0.003), and higher superoxide dismutase enzyme activity (p<0.001). Furthermore, the histopathological analysis indicated that genistein administration led to an increase in luteinization and the development of fewer cysts (p<0.05). Conclusion: Biochemical and histopathological analyses indicated that genistein administration to rats with PCOS induced significant remission in oxidative, inflammatory, and glycemic and histopathologic parameters (all p<0.05).

참고문헌 (Reference)

1 Ashkar F, "The role of medicinal herbs in treatment of insulin resistance in patients with polycystic ovary syndrome : a literature review" 11 : 57-75, 2020

2 Doaei S, "The role of FTO genotype in the association between FTO gene expression and anthropometric measures in obese and overweight adolescent boys" 13 : 1557988318808119-, 2019

3 Chi XX, "The regulatory effect of Genistein on granulosa cell in ovary of rat with PCOS through Bcl-2 and Bax signaling pathways" 80 : 1348-1355, 2018

4 Ding T, "The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity : a systematic review and meta-analysis" 8 : 96351-96358, 2017

5 Incir S, "The effects of genistein supplementation on fructose induced insulin resistance, oxidative stress and inflammation" 158 : 57-62, 2016

6 Shidfar F, "The effects of extra virgin olive oil on alanine aminotransferase, aspartate aminotransferase, and ultrasonographic indices of hepatic steatosis in nonalcoholic fatty liver disease patients undergoing low calorie diet" 2018 : 1053710-, 2018

7 Lv WS, "The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats" 1444 : 11-19, 2012

8 Sherif HS, "Synthesis, characterization, and antioxidant activities of genistein, biochanin a, and their analogues" 2018 : 4032105-, 2018

9 Rajan RK, "Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome(PCOS)model through anti-androgenic mechanism" 55 : 242-251, 2017

10 Ha BG, "Regulatory mechanism for the stimulatory action of genistein on glucose uptake in vitro and in vivo" 23 : 501-509, 2012

11 Gonzalez F, "Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome" 91 : 336-340, 2006

12 Ciaraldi TP, "Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance" 94 : 157-163, 2009

13 Sabuncu T, "Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease" 34 : 407-413, 2001

14 Agarwal A, "Oxidative stress and its implications in female infertility : a clinician’s perspective" 11 : 641-650, 2005

15 Serafini M, "Modulation of plasma non enzimatic antioxidant capacity(NEAC)by plant foods : the role of polyphenols" 11 : 1821-1846, 2011

16 DeFronzo RA, "Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects" 73 : 1294-1301, 1991

17 Romualdi D, "Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study" 90 : 1826-1833, 2008

18 Shorakae S, "Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS" 89 : 628-633, 2018

19 Corbould A, "Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling" 288 : E1047-54, 2005

20 Henin N, "Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase" 9 : 541-546, 1995

21 Gonzalez F, "Inflammation in polycystic ovary syndrome : underpinning of insulin resistance and ovarian dysfunction" 77 : 300-305, 2012

22 Ben Djoudi Ouadda A, "Increased hepatic lipogenesis in insulin resistance and type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus" 29 : 283-292, 2009

23 Borras C, "Genistein, a soy isoflavone, up-regulates expression of antioxidant genes : involvement of estrogen receptors, ERK1/2, and NFkappaB" 20 : 2136-2138, 2006

24 Simperova A, "Genistein supplementation prevents weight gain but promotes oxidative stress and inflammation in the vasculature of female obese ob/ob mice" 36 : 789-797, 2016

25 Choi JS, "Genistein reduced insulin resistance index through modulating lipid metabolism in ovariectomized rats" 32 : 844-855, 2012

26 Mohamed Salih S, "Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance" 1 : 278-287, 2009

27 Kim S, "Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha" 220 : 51-58, 2004

28 Susutlertpanya W, "Genistein attenuates nonalcoholic steatohepatitis and increases hepatic PPARγ in a rat model" 2015 : 509057-, 2015

29 Fu Z, "Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes" 37 : 480-488, 2012

30 Heim KE, "Flavonoid antioxidants : chemistry, metabolism and structure-activity relationships" 13 : 572-584, 2002

31 Pawelczak M, "Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome" 27 : 356-359, 2014

32 Zhang T, "Estrogenic properties of genistein acting on FSHR and LHR in rats with PCOS" 22 : 83-90, 2019

33 Liu H, "Effects of soy isoflavone on hepatic steatosis in high fat-induced rats" 61 : 85-90, 2017

34 Doaei S, "Effects of gene polymorphisms of metabolic enzymes on the association between red and processed meat consumption and the development of colon cancer; a literature review" 7 : e26-, 2018

35 Palanisamy N, "Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet" 30 : 645-654, 2008

36 Choi JS, "Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats" 25 : 676-685, 2009

37 Pearson G, "ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation" 276 : 7927-7931, 2001

38 Yoo NY, "Dietary supplementation of genistein alleviates liver inflammation and fibrosis mediated by a methionine-choline-deficient diet in db/db Mice" 63 : 4305-4311, 2015

39 Fenkci V, "Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease" 80 : 123-127, 2003

40 Corbould A, "Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women" 192 : 585-594, 2007

41 Satoh K, "Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders" 45 : 1335-1341, 1981

42 Huang Y, "Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes" 40 : 461-465, 2015

43 Lotfi MH, "Association of food groups intake and physical activity with gestational diabetes mellitus in Iranian women" 33 : 3559-3564, 2020

44 Kim HP, "Anti-inflammatory plant flavonoids and cellular action mechanisms" 96 : 229-245, 2004

45 Ji G, "Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms" 11 : 762-768, 2011

46 Gilbert ER, "Anti-diabetic functions of soy isoflavone genistein : mechanisms underlying its effects on pancreatic β-cell function" 4 : 200-212, 2013

47 Zaheer K, "An updated review of dietary isoflavones : nutrition, processing, bioavailability and impacts on human health" 57 : 1280-1293, 2017

48 Spritzer PM, "Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome" 149 : R219-27, 2015

49 Konig B, "Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2" 73 : 574-585, 2007

50 Manneras L, "A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome" 148 : 3781-3791, 2007

51 최정남, "2'-Hydroxylation of Genistein Enhanced Antioxidant and Antiproliferative Activities in MCF-7 Human Breast Cancer Cells" 한국미생물·생명공학회 19 (19): 1348-1354, 2009